Editorial · 2017

Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?

David M. Taylor

CNS Drugs, 31(3), 177–180 · Published 1 March 2017 · DOI 10.1007/s40263-017-0411-6

View at the publisherCite this paper

In brief

“Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?” is an 2017 editorial by David M. Taylor, published in CNS Drugs. OpenAlex counts 73 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
73
Most cited in
2021 (12)
References
26
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Taylor, D. M. (2017). Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard? CNS Drugs, 31(3), 177–180. https://doi.org/10.1007/s40263-017-0411-6

MLA 9

Taylor, David M. “Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?” CNS Drugs, vol. 31, no. 3, 2017, pp. 177–180. https://doi.org/10.1007/s40263-017-0411-6.

Chicago

Taylor, David M. 2017. “Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?” CNS Drugs 31 (3): 177–180. https://doi.org/10.1007/s40263-017-0411-6.

Harvard

Taylor, D. M. (2017) ‘Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?’, CNS Drugs, 31(3), pp. 177–180. doi:10.1007/s40263-017-0411-6.

IEEE

D. M. Taylor, “Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?,” CNS Drugs, vol. 31, no. 3, pp. 177–180, 2017, doi: 10.1007/s40263-017-0411-6.

BibTeX

@article{taylor2017clozapine,
  title     = {{Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?}},
  author    = {Taylor, David M.},
  journal   = {CNS Drugs},
  year      = {2017},
  volume    = {31},
  number    = {3},
  pages     = {177--180},
  doi       = {10.1007/s40263-017-0411-6},
  url       = {https://doi.org/10.1007/s40263-017-0411-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201744
201833
201966
202099
20211212
202299
202399
202422
20251010
202699

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • clozapine
  • treatment-resistant schizophrenia
  • antipsychotic drugs
  • atypical antipsychotics
  • antipsychotic efficacy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Taylor, D. M. (2017). Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard? CNS Drugs, 31(3), 177–180. https://doi.org/10.1007/s40263-017-0411-6

How many times has this paper been cited?

73 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

David M. Taylor.

What is the DOI of this paper?

10.1007/s40263-017-0411-6, permanently at https://doi.org/10.1007/s40263-017-0411-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.